Saito Biotech: “Asset Evaluation Report on the Asset Assessment Project for All Silver Valley Pharmaceutical Shareholders' Equity Value Assessment Project Involved in the Proposed Acquisition of Shares by Shandong Saito Biotechnology Co., Ltd.”

SZSI · Mar 1

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

赛托生物：《山东赛托生物科技股份有限公司拟收购股权涉及的银谷制药股东全部权益价值评估项目资产评估报告》

Saito Biotech: “Asset Evaluation Report on the Asset Assessment Project for All Silver Valley Pharmaceutical Shareholders' Equity Value Assessment Project Involved in the Proposed Acquisition of Shares by Shandong Saito Biotechnology Co., Ltd.”

Risk Disclaimer

Statement